Your browser doesn't support javascript.
loading
Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis.
Bracco Gartner, Thomas C L; Crnko, Sandra; Leiteris, Laurynas; van Adrichem, Iris; van Laake, Linda W; Bouten, Carlijn V C; Goumans, Marie José; Suyker, Willem J L; Sluijter, Joost P G; Hjortnaes, Jesper.
Afiliación
  • Bracco Gartner TCL; Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, Netherlands.
  • Crnko S; Regenerative Medicine Center Utrecht, Circulatory Health Laboratory, Utrecht, Netherlands.
  • Leiteris L; Experimental Cardiology Laboratory, Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
  • van Adrichem I; Regenerative Medicine Center Utrecht, Circulatory Health Laboratory, Utrecht, Netherlands.
  • van Laake LW; Experimental Cardiology Laboratory, Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Bouten CVC; Regenerative Medicine Center Utrecht, Circulatory Health Laboratory, Utrecht, Netherlands.
  • Goumans MJ; Regenerative Medicine Center Utrecht, Circulatory Health Laboratory, Utrecht, Netherlands.
  • Suyker WJL; Regenerative Medicine Center Utrecht, Circulatory Health Laboratory, Utrecht, Netherlands.
  • Sluijter JPG; Experimental Cardiology Laboratory, Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Hjortnaes J; Department of Biomedical Technology, Eindhoven University of Technology, Eindhoven, Netherlands.
Front Cardiovasc Med ; 9: 854314, 2022.
Article en En | MEDLINE | ID: mdl-35360018

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos